Work

156eP Integrated metabolomic and tumor microenvironment profiling identifies predictive biomarkers for immunotherapy response in advanced NSCLC

Year: 2026

Type: article

Abstract: To identify biomarkers predictive of response to first-line immune-checkpoint inhibitor combined chemotherapy in advanced NSCLC, we performed a prospective longitudinal study coupling serial serum metabolomics with tumor tissue analysis.

Source: ESMO Open

DOI: 10.1016/j.esmoop.2026.106463

Authors: L. Yang, A. Aili, B. Cao

Institution: Peking University Third Hospital

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,910

OpenAlex ID: W7137972004

FWCI:

Cites:

Cited by:

Related to: